Preview Mode Links will not work in preview mode


TopMedTalk for the latest medical news: Live updates from conferences; Journal Club; Techno-Talk; Interactive phone-in discussions; and Hot-Topic podcasts. Continuing Medical Education (CME) on the go.


Sep 29, 2019

Is it still ethically viable to have a standard arm in a prehabilitation trial? Which allied health professionals supervises the exercise part of these trials? What are the biggest reasons for non-adherence to home based exercise programmes? How do you address a possible selection bias with candidates? What is the best time to follow up a study with these patients?

Featuring; Krishna Moorthy Senior Lecturer, Consultant Surgeon, Imperial College London, Academic surgeon, with research interests in patient safety and quality of improvement in surgery, Co-lead of the PREPARE for surgery prehabilitation programme, BMJ Surgical Team of the year and Patient Participation awards 2017, Consultant Surgeon, BMI Healthcare, Consultant Surgeon the Wellington Hospital; Denny Levett, Professor in Perioperative Medicine and Critical Care at the University of Southampton and a Consultant in Perioperative Medicine at Southampton University Hospital NHS Foundation trust; Suzanne Mcdonald, Research Associate at The University of Queensland (Australia), Visiting Researcher at Newcastle University (UK) and registered Chartered Health Psychologist; Charlotte Molenaar, PhD Candidate, multimodal prehabilitation in colorectal cancer care, BIJ Maxima Medisch Centrum, Coordinator of the international PREHAB trial; Professor Sandy Jack, PhD, Consultant Clinician Scientist in the Anaesthesia and Critical Care Research Unit at University Hospital Southampton NHS Foundation Trust, Southampton and NIHR Southampton Respiratory Biomedical Research Unit and Integrated Physiology and Critical Illness Group, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Honorary Senior Lecturer at the University of Liverpool, University of Southampton and University College London; James Hernon, Consultant Colorectal Surgeon, Norfolk and Norwich University Hospital NHS Foundation Trust, Chair of the Anglia Cancer Colorectal Network, CO-CI for PREPARE ABC a NIHR HTA funded randomised clinical study.